Document Type : Original Article

Author

Assistant Professor, Department of Basic Sciences, Hamedan University of Technology, Hamedan, Iran

Abstract

Introduction: In obesity, the serum levels of Asprosin are pathologically upregulated, this is thus considered a therapeutic target. This study aimed to explore the effect of exercise training as combined training (Aerobic+ Resistance training) along with Caffeine supplementation on the plasma levels of Asprosin in middle-aged obese men.
Materials and Methods: 38 obese men aged 35 to 50 years, with a BMI of greater than 28 participated in the research. They were stratified randomized into 4 groups. including: 1-Control-placebo (n=10), 2- Caffeine (n=10), 3- Combined training-placebo (n=9) and 4- Caffeine and combined training (n=9). The caffeine group consumed the caffeine tab 4.5 mg per kg body weight, daily, for 6 weeks. The Combined training group had concurrent aerobic and resistance training for 6 weeks (3 sessions per week). Blood samples were collected before and after the intervention, and the plasma asprosin concentration was measured by the ELISA method.
Results: By the effect of the Combined training, the Asprosin level was reduced (p=0/01). Taking Caffeine alone did not significantly reduce Asprosin (p=0/19). The Asprosin declined in the group that had both Combined training and Caffeine (p=0/01).
Conclusion: In order to reduce the upregulated Asprosin in obese individuals known as pathologic, combined training is recommended and/so it is not necessary to take caffeine along with the training.

Keywords

Main Subjects

  1. Sarma S, Sockalingam S, Dash S. Obesity as a multisystem disease: Trends in obesity rates and obesity‐related complications. Diabetes, Obesity and Metabolism. 2021;23:3-16. DOI: 10.1111/dom.14290
  2. Kajimura S. Advances in the understanding of adipose tissue biology. Nature Reviews Endocrinology. 2017;13(2):69-70. DOI: 10.1038/nrendo.2016.211
  3. Ceylan Hİ, Saygın Ö. An investigation of the relationship between new fasting hormone asprosin, obesity and acute–chronic exercise: current systematic review. Archives of Physiology and Biochemistry. 2021;127(4):373- DOI: 10.1080/13813455.2020.1767652
  4. Taylor EB. The complex role of adipokines in obesity, inflammation, and autoimmunity. Clinical Science. 2021;135(6):731-52. DOI: 10.1042/CS20200895
  5. Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F, et al. Asprosin, a Fasting-Induced Glucogenic Protein Hormone. Cell. 2016;165(3):566-79. DOI: 10.1016/j.cell.2016.02.063
  6. Duerrschmid C, He Y, Wang C, Li C, Bournat JC, Romere C, et al. Asprosin is a centrally acting orexigenic hormone. Nature medicine. 2017;23(12):1444-53. DOI: 10.1038/nm.4432
  7. Jung TW, Kim HC, Kim HU, Park T, Park J, Kim U, et al. Asprosin attenuates insulin signaling pathway through PKCδ‐activated ER stress and inflammation in skeletal muscle. Journal of cellular physiology. 2019;234(11):20888-99. DOI: 10.1002/jcp.28694
  8. Lee T, Yun S, Jeong JH, Jung TW. Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation. Molecular and cellular endocrinology. 2019;486:96-104. DOI: 10.1016/j.mce.2019.03.001
  9. Ugur K, Aydin S. Saliva and Blood Asprosin Hormone Concentration Associated with Obesity. International Journal of Endocrinology. 2019; 2521096. DOI: 10.1155/2019/2521096
  10. Wang M, Yin C, Wang L, Liu Y, Li H, Li M, et al. Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity. Annals of Nutrition and Metabolism. 2019;75(4):205-12. DOI: 10.1159/000503808
  11. Sünnetçi Silistre E, Hatipoğl HU. Increased serum circulating asprosin levels in children with obesity. Pediatrics International. 2020;62(4):467-76. DOI: 10.1111/ped.14176
  12. Wang M, Yin C, Wang L, Liu Y, Li H, Li M, et al. Serum asprosin concentrations are increased and associated with insulin resistance in children with obesity. Annals of nutrition and metabolism. 2020;75(4):205-12. DOI: 10.1159/000503808
  13. Hong T, Li J-Y, Wang Y-D, Qi X-Y, Liao Z-Z, Bhadel P, et al. High serum asprosin levels are associated with presence of metabolic syndrome. International journal of endocrinology. 2021;2021. DOI: 10.1155/2021/6622129
  14. Wang Y, Qu H, Xiong X, Qiu Y, Liao Y, Chen Y, et al. Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion. Mediators of inflammation. 2018; 9471583. DOI: 10.1155/2018/9471583
  15. Zhang L, Chen C, Zhou N, Fu Y, Cheng X. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride. Clinica chimica acta. 2019;489:183-8. DOI: 10.1016/j.cca.2017.10.034
  16. Li X, Liao M, Shen R, Zhang L, Hu H, Wu J, et al. Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases. Mediators of inflammation. 2018;7375294. DOI: 10.1155/2018/7375294
  17. Cheng J-X, Yu K. New discovered adipokines associated with the pathogenesis of obesity and type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2022:2381-9. DOI: 10.2147/DMSO.S376163
  18. Saeidi A, Haghighi MM, Kolahdouzi S, Daraei A, Abderrahmane AB, Essop MF, et al. The effects of physical activity on adipokines in individuals with overweight/obesity across the lifespan: A narrative review. Obesity Reviews. 2021;22(1):e13090. DOI: 10.1111/obr.13090
  19. Kantorowicz M, Szymura J, Szygula Z, Kusmierczyk J, Maciejczyk M, Wiecek M. Nordic walking at maximal fat oxidation intensity decreases circulating asprosin and visceral obesity in women with metabolic disorders. Frontiers in Physiology. 2021;12:726783. DOI: 10.3389/fphys.2021.726783
  20. Dolataabadi P, Amirsasan R, Vakili J. The effect of high-intensity interval training on serum asprosin and lipid profile of overweight and obese Women. Journal of Practical Studies of Biosciences in Sport. 2023;11(27):22-33. (Persian). DOI: 10.22077/jpsbs.2022.5292.1714
  21. Dolataabadi P, Amirsasan R, Vakili J. The effect of high-intensity circuit training on serum asprosin, lipid profile and some fitness factors in overweight and obese women. Journal of Applied Health Studies in Sport Physiology. 2023;10(1):14-26. (Persian). DOI: 10.22049/JAHSSP.2022.27792.1464
  22. Tabrizi R, Saneei P, Lankarani KB, Akbari M, Kolahdooz F, Esmaillzadeh A, et al. The effects of caffeine intake on weight loss: a systematic review and dos-response meta-analysis of randomized controlled trials. Critical reviews in food science and nutrition. 2019;59(16):2688-96. DOI: 10.1080/10408398.2018.1507996
  23. Gavrieli A, Karfopoulou E, Kardatou E, Spyreli E, Fragopoulou E, Mantzoros CS, et al. Effect of different amounts of coffee on dietary intake and appetite of normal-weight and overweight/obese individuals. Obesity. 2013;21(6):1127-32. DOI: 10.1002/oby.20190
  24. Karimnezhad N, Mahdavi Roshan M, Izaddost F, Shabani R. The simultaneous effects of green coffee and combine exercise training on body composition and glucose homeostasis in obese and overweight women. Journal of Medicinal Plants. 2019;18(72):215-27. (Persian). http://jmp.ir/article-1-1778-en.html
  25. Zarei M, Nakhzari Khodakheyr J, Rashidlamir A, Montazeri A. The effect of combined resistance aerobic exercise training on concentrations of asprosin and complement C1q tumor necrosis factor-related protein-1 in men with type 2 diabetes. Sport Sciences for Health. 2021:1-9. DOI: 10.1007/s11332-021-00738-7
  26. Yuan M, Li W, Zhu Y, Yu B, Wu J. Asprosin: a novel player in metabolic diseases. Frontiers in endocrinology. 2020;11:64. DOI: 10.3389/fendo.2020.00064
  27. López-Cruz L, Salamone JD, Correa M. Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression. Frontiers in Pharmacology. 2018;9. DOI: 10.3389/fphar.2018.00526
  28. Moon S-M, Joo M-J, Lee Y-S, Kim M-G. Effects of coffee consumption on insulin resistance and sensitivity: a meta-analysis. Nutrients. 2021;13(11):3976. DOI: 10.3390/nu13113976
  29. Lee CB, Yu SH, Kim NY, Kim SM, Kim SR, Oh SJ, et al. Association between coffee consumption and circulating levels of adiponectin and leptin. Journal of medicinal food. 2017;20(11):1068-75. DOI: 10.1089/jmf.2017.3959
  30. Denden S, Bouden B, Haj Khelil A, Ben Chibani J, Hamdaoui M. Gender and ethnicity modify the association between the CYP1A2 rs762551 polymorphism and habitual coffee intake: evidence from a meta-analysis. Genet Mol Res. 2016;15(2). DOI: 10.4238/gmr.1502748
  31. Gkouskou KG, Georgiopoulos G, Vlastos I, Lazou E, Chaniotis D, Papaioannou TG, et al. CYP1A2 polymorphisms modify the association of habitual coffee consumption with appetite, macronutrient intake, and body mass index: results from an observational cohort and a cross-over randomized study. International Journal of Obesity. 2022;46(1):162-8. DOI: 10.1038/s41366-021-00972-6
  32. Sheikholeslami-Vatani D, Siahkouhian M, Hakimi M, Ali-Mohammadi M. The effect of concurrent training order on hormonal responses and body composition in obese men. Science & Sports. 2015;30(6):335-41. DOI: 10.1016/j.scispo.2015.06.005
  33. Said MA, Abdelmoneim MA, Alibrahim MS, Kotb AAH. Aerobic training, resistance training, or their combination as a means to fight against excess weight and metabolic syndrome in obese students — which is the most effective modality? A randomized controlled trial. Applied Physiology, Nutrition, and Metabolism. 2021;46(8):952-63. DOI: 10.1139/apnm-2020-0972
  34. Liu CW, Tsai HC, Huang CC, Tsai CY, Su YB, Lin MW, Lee KC, Hsieh YC, Li TH, Huang SF, Yang YY. Effects and mechanisms of caffeine to improve immunological and metabolic abnormalities in diet-induced obese rats. American Journal of Physiology-Endocrinology and Metabolism. 2018;314(5):E433-47. DOI:10.1152/ajpendo.00094.2017